Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Reduced Endocannabinoid Tone in Saliva of Chronic Orofacial Pain Patients.

< BACK TO ARCHIVE


2022 Jul 21


Molecules


http://www.ncbi.nlm.nih.gov/pubmed/35889535?dopt=Abstract


27


14

Reduced Endocannabinoid Tone in Saliva of Chronic Orofacial Pain Patients.

Authors

Reduced Endocannabinoid Tone in Saliva of Chronic Orofacial Pain Patients.
Haviv Y, Georgiev O, Gaver-Bracha T, Hamad S, Nemirovski A, Hadar R, Sharav Y, Aframian DJ, Brotman Y, Tam J
Molecules. 2022 Jul 21; 27(14).
PMID: 35889535.

Abstract

the endocannabinoid system (ECS) participates in many physiological and pathological processes including pain generation, modulation, and sensation. Its involvement in chronic orofacial pain (OFP) in general, and the reflection of its involvement in OFP in salivary endocannabinoid (eCBs) levels in particular, has not been examined.
Read This Paper